 DALLAS, June 23, 2021 PRNewswire -- SWK Holdings Corporation Nasdaq: SWKH SWK or the Company, a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that its Board of Directors has authorized the Company to repurchase up to an aggregate of 5.0 million of the Companys Common Stock from time to time until March 15, 2022 through a 10b5-1 trading plan in compliance with Rule 10b-18 under the Securities Exchange Act of 1934. The actual timing, number and value of shares repurchased under the program will depend on a number of factors, including the constraints specified in the 10b5-1 trading plan, price, and general market conditions. 